Search the Newsroom
Filter By
Showing 1 - 10 of 2707 results
Researchers Find Facemask Impacts are Leading Source of Higher Severity Impacts in Professional American Football
Facemasks accounted for over half of the top 10% of head impacts experienced by players in the study, highlighting the importance of prioritizing new helmet designs
September 2024: Vaccines and Infectious Diseases in the News
Get updates on polio, mpox, H5N1 and measles.
Children’s Hospital of Philadelphia Research Sheds Light on Diuretic Use in Preterm Babies with Bronchopulmonary Dysplasia
Researchers from Children’s Hospital of Philadelphia (CHOP) announced findings from a new study that show outpatient diuretic use is common in children with bronchopulmonary dysplasia (BPD), and that factors such as gestational age, severity of BPD, and type of diuretic significantly influenced the timing of medication weaning. The study was published recently in Pediatric Pulmonology.
Feature Article: People Are Asking, “Should I Get a COVID-19 Vaccine This Fall?”
Get information about four aspects of COVID-19 and the vaccine to consider when deciding about getting booster doses.
Dr. Handy’s Corner: Why Should Kids Get the Influenza and COVID-19 Vaccines If the Diseases Aren’t That Serious?
Dr. Lori Handy recounts a family’s experience with influenza. She also describes the symptoms of influenza and COVID-19 and talks about the importance of getting children vaccinated.
Vaccine News & Notes — September 2024
Check out our redesigned websites; learn about a new book to help families navigate vaccine decisions; and see updates related to RSV vaccine use in adults.
CHOP Researchers Develop Innovative Model Offering New Insights to Improve and Overcome Current Obstacles in Hemophilia A Gene Therapy
Researchers at CHOP announced the results of a new study offering insights into the development of next-generation gene therapies to treat hemophilia A.
Just the Vax Trivia Corner
Which vaccinologist is buried in Arlington National Cemetery? Find out.
Children’s Hospital of Philadelphia Researchers Find Promising Preclinical Results for High-Risk Neuroblastoma
Researchers at Children’s Hospital of Philadelphia (CHOP) demonstrated a promising new approach in the fight against high-risk neuroblastoma, a common and potentially deadly childhood cancer that can occur within the peripheral nervous system. The study, recently published in Nature Communications, found that chimeric antigen receptor (CAR) T-cell therapy targeting two markers on neuroblastoma cancer cells simultaneously boosted overall immune response by engaging adaptive and innate immunity in preclinical models.
Researchers at Children’s Hospital of Philadelphia Advocate for Energy Drink Regulation
Energy drinks, marketed for boosting energy, concentration, and athletic performance, can pose significant cardiovascular risks, including death. Despite the American Academy of Pediatrics’ advice against caffeine consumption by children and adolescents, the United States remains the least regulated country and should take immediate steps to protect vulnerable populations, leading cardiology researchers at Children’s Hospital of Philadelphia (CHOP) urged in a recent commentary in the Journal of Pediatrics.